APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exoskeleton Enhancement Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchExoskeleton Enhancement Device Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Exoskeleton Enhancement Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exoskeleton Enhancement Device include Parker Hannifin, US Bionics, ReWalk Robotics, Panasonic, Myomo, LockHeed Martin, Interactive Motion Technologies, Hocoma and Ekso Bionics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Exoskeleton Enhancement Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exoskeleton Enhancement Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exoskeleton Enhancement Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exoskeleton Enhancement Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Exoskeleton Enhancement Device Segment by Company

Parker Hannifin

US Bionics

ReWalk Robotics

Panasonic

Myomo

LockHeed Martin

Interactive Motion Technologies

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Alter G

Exoskeleton Enhancement Device Segment by Type

Lower

Upper

Full Body

Exoskeleton Enhancement Device Segment by Application

Healthcare

Defense

Others

Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exoskeleton Enhancement Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Exoskeleton Enhancement Device Industry Trends Table 2. Exoskeleton Enhancement Device Industry Drivers Table 3. Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 4. Exoskeleton Enhancement Device Industry Restraints Table 5. Global Exoskeleton Enhancement Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Exoskeleton Enhancement Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Exoskeleton Enhancement Device Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Exoskeleton Enhancement Device Sales Market Share by Manufacturers Table 9. Global Exoskeleton Enhancement Device Average Sales Price (K US$/Unit) of Manufacturers (2021-2026) Table 10. Global Exoskeleton Enhancement Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Exoskeleton Enhancement Device Manufacturers, Product Type & Application Table 13. Global Exoskeleton Enhancement Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Exoskeleton Enhancement Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lower Table 17. Major Manufacturers of Upper Table 18. Major Manufacturers of Full Body Table 19. Global Exoskeleton Enhancement Device Sales by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 21. Global Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 22. Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2026) Table 23. Global Exoskeleton Enhancement Device Sales Market Share by Type (2027-2032) Table 24. Global Exoskeleton Enhancement Device Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 25. Global Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (Units) Table 26. Global Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (Units) Table 27. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2026) Table 28. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Healthcare Table 30. Major Manufacturers of Defense Table 31. Major Manufacturers of Others Table 32. Global Exoskeleton Enhancement Device Sales by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 34. Global Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 35. Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2026) Table 36. Global Exoskeleton Enhancement Device Sales Market Share by Application (2027-2032) Table 37. Global Exoskeleton Enhancement Device Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (Units) Table 39. Global Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (Units) Table 40. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2026) Table 41. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2027-2032) Table 42. Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 44. Global Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 45. Global Exoskeleton Enhancement Device Sales Forecasted by Region (2027-2032) & (Units) Table 46. Global Exoskeleton Enhancement Device Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 48. North America Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 49. North America Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 50. Europe Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. Europe Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 52. Europe Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 53. Asia Pacific Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Asia Pacific Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 55. Asia Pacific Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 56. South America, Middle East and Africa Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. South America, Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 58. South America, Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 59. Global Exoskeleton Enhancement Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Exoskeleton Enhancement Device Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Exoskeleton Enhancement Device Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2026) Table 63. Global Exoskeleton Enhancement Device Revenue Market Share by Region (2027-2032) Table 64. Parker Hannifin Company Information Table 65. Parker Hannifin Business Overview Table 66. Parker Hannifin Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Parker Hannifin Exoskeleton Enhancement Device Product Portfolio Table 68. Parker Hannifin Recent Development Table 69. US Bionics Company Information Table 70. US Bionics Business Overview Table 71. US Bionics Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. US Bionics Exoskeleton Enhancement Device Product Portfolio Table 73. US Bionics Recent Development Table 74. ReWalk Robotics Company Information Table 75. ReWalk Robotics Business Overview Table 76. ReWalk Robotics Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio Table 78. ReWalk Robotics Recent Development Table 79. Panasonic Company Information Table 80. Panasonic Business Overview Table 81. Panasonic Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Panasonic Exoskeleton Enhancement Device Product Portfolio Table 83. Panasonic Recent Development Table 84. Myomo Company Information Table 85. Myomo Business Overview Table 86. Myomo Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Myomo Exoskeleton Enhancement Device Product Portfolio Table 88. Myomo Recent Development Table 89. LockHeed Martin Company Information Table 90. LockHeed Martin Business Overview Table 91. LockHeed Martin Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. LockHeed Martin Exoskeleton Enhancement Device Product Portfolio Table 93. LockHeed Martin Recent Development Table 94. Interactive Motion Technologies Company Information Table 95. Interactive Motion Technologies Business Overview Table 96. Interactive Motion Technologies Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio Table 98. Interactive Motion Technologies Recent Development Table 99. Hocoma Company Information Table 100. Hocoma Business Overview Table 101. Hocoma Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hocoma Exoskeleton Enhancement Device Product Portfolio Table 103. Hocoma Recent Development Table 104. Ekso Bionics Company Information Table 105. Ekso Bionics Business Overview Table 106. Ekso Bionics Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Ekso Bionics Exoskeleton Enhancement Device Product Portfolio Table 108. Ekso Bionics Recent Development Table 109. Cyberdyne Company Information Table 110. Cyberdyne Business Overview Table 111. Cyberdyne Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Cyberdyne Exoskeleton Enhancement Device Product Portfolio Table 113. Cyberdyne Recent Development Table 114. B-TEMIA Inc. Company Information Table 115. B-TEMIA Inc. Business Overview Table 116. B-TEMIA Inc. Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio Table 118. B-TEMIA Inc. Recent Development Table 119. Alter G Company Information Table 120. Alter G Business Overview Table 121. Alter G Exoskeleton Enhancement Device Sales (Units), Price (K US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Alter G Exoskeleton Enhancement Device Product Portfolio Table 123. Alter G Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Exoskeleton Enhancement Device Distributors List Table 127. Exoskeleton Enhancement Device Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Exoskeleton Enhancement Device Product Image Figure 2. Global Exoskeleton Enhancement Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoskeleton Enhancement Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 5. Global Exoskeleton Enhancement Device Average Price (K US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Exoskeleton Enhancement Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lower Image Figure 9. Upper Image Figure 10. Full Body Image Figure 11. Global Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Exoskeleton Enhancement Device Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032) Figure 14. Global Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global Exoskeleton Enhancement Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032) Figure 17. Healthcare Image Figure 18. Defense Image Figure 19. Others Image Figure 20. Global Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Exoskeleton Enhancement Device Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032) Figure 23. Global Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Exoskeleton Enhancement Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032) Figure 26. North America Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 27. North America Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 28. U.S. Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 29. Canada Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 30. Mexico Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 33. Germany Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 34. France Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 35. U.K. Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 36. Italy Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 37. Netherlands Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 40. China Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 41. Japan Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 42. South Korea Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 43. Southeast Asia Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 44. India Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 45. Australia Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 48. Brazil Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 49. South Africa Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 50. Saudi Arabia Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 51. Turkey Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 52. Argentina Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 53. UAE Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 54. Egypt Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 55. Chile Exoskeleton Enhancement Device Sales and Growth Rate (2021-2032) & (Units) Figure 56. Global Exoskeleton Enhancement Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Exoskeleton Enhancement Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 59. North America Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 61. Europe Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Exoskeleton Enhancement Device Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Exoskeleton Enhancement Device Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Exoskeleton Enhancement Device Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Lower
  • Upper
  • Full Body
Applications
  • Healthcare
  • Defense
  • Others
Companies covered
  • Parker Hannifin
  • US Bionics
  • ReWalk Robotics
  • Panasonic
  • Myomo
  • LockHeed Martin
  • Interactive Motion Technologies
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Exoskeleton Enhancement Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Exoskeleton Enhancement Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Exoskeleton Enhancement Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Exoskeleton Enhancement Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Exoskeleton Enhancement Device Market Dynamics
  1. 2.1 Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Exoskeleton Enhancement Device Industry Restraints
3 Exoskeleton Enhancement Device Market by Manufacturers
  1. 3.1 Global Exoskeleton Enhancement Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Exoskeleton Enhancement Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Exoskeleton Enhancement Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Exoskeleton Enhancement Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Exoskeleton Enhancement Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Exoskeleton Enhancement Device Manufacturers, Product Type & Application
  7. 3.7 Global Exoskeleton Enhancement Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Exoskeleton Enhancement Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Exoskeleton Enhancement Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3
4 Exoskeleton Enhancement Device Market by Type
  1. 4.1 Exoskeleton Enhancement Device Type Introduction
  2. 4.1.1 Lower
  3. 4.1.2 Upper
  4. 4.1.3 Full Body
  5. 4.2 Global Exoskeleton Enhancement Device Sales by Type
  6. 4.2.1 Global Exoskeleton Enhancement Device Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Exoskeleton Enhancement Device Sales by Type (2021-2032)
  8. 4.2.3 Global Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032)
  9. 4.3 Global Exoskeleton Enhancement Device Revenue by Type
  10. 4.3.1 Global Exoskeleton Enhancement Device Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  12. 4.3.3 Global Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032)
5 Exoskeleton Enhancement Device Market by Application
  1. 5.1 Exoskeleton Enhancement Device Application Introduction
  2. 5.1.1 Healthcare
  3. 5.1.2 Defense
  4. 5.1.3 Others
  5. 5.2 Global Exoskeleton Enhancement Device Sales by Application
  6. 5.2.1 Global Exoskeleton Enhancement Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exoskeleton Enhancement Device Sales by Application (2021-2032)
  8. 5.2.3 Global Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Exoskeleton Enhancement Device Revenue by Application
  10. 5.3.1 Global Exoskeleton Enhancement Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032)
6 Global Exoskeleton Enhancement Device Sales by Region
  1. 6.1 Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exoskeleton Enhancement Device Sales by Region (2021-2032)
  3. 6.2.1 Global Exoskeleton Enhancement Device Sales by Region (2021-2026)
  4. 6.2.2 Global Exoskeleton Enhancement Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Exoskeleton Enhancement Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Exoskeleton Enhancement Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Exoskeleton Enhancement Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Exoskeleton Enhancement Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Exoskeleton Enhancement Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Exoskeleton Enhancement Device Revenue by Region
  1. 7.1 Global Exoskeleton Enhancement Device Revenue by Region
  2. 7.1.1 Global Exoskeleton Enhancement Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Exoskeleton Enhancement Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Exoskeleton Enhancement Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Exoskeleton Enhancement Device Revenue (2021-2032)
  8. 7.2.2 North America Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Exoskeleton Enhancement Device Revenue (2021-2032)
  11. 7.3.2 Europe Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Exoskeleton Enhancement Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Exoskeleton Enhancement Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Exoskeleton Enhancement Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Parker Hannifin
  2. 8.1.1 Parker Hannifin Company Information
  3. 8.1.2 Parker Hannifin Business Overview
  4. 8.1.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
  6. 8.1.5 Parker Hannifin Recent Developments
  7. 8.2 US Bionics
  8. 8.2.1 US Bionics Company Information
  9. 8.2.2 US Bionics Business Overview
  10. 8.2.3 US Bionics Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
  12. 8.2.5 US Bionics Recent Developments
  13. 8.3 ReWalk Robotics
  14. 8.3.1 ReWalk Robotics Company Information
  15. 8.3.2 ReWalk Robotics Business Overview
  16. 8.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
  18. 8.3.5 ReWalk Robotics Recent Developments
  19. 8.4 Panasonic
  20. 8.4.1 Panasonic Company Information
  21. 8.4.2 Panasonic Business Overview
  22. 8.4.3 Panasonic Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
  24. 8.4.5 Panasonic Recent Developments
  25. 8.5 Myomo
  26. 8.5.1 Myomo Company Information
  27. 8.5.2 Myomo Business Overview
  28. 8.5.3 Myomo Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Myomo Exoskeleton Enhancement Device Product Portfolio
  30. 8.5.5 Myomo Recent Developments
  31. 8.6 LockHeed Martin
  32. 8.6.1 LockHeed Martin Company Information
  33. 8.6.2 LockHeed Martin Business Overview
  34. 8.6.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
  36. 8.6.5 LockHeed Martin Recent Developments
  37. 8.7 Interactive Motion Technologies
  38. 8.7.1 Interactive Motion Technologies Company Information
  39. 8.7.2 Interactive Motion Technologies Business Overview
  40. 8.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
  42. 8.7.5 Interactive Motion Technologies Recent Developments
  43. 8.8 Hocoma
  44. 8.8.1 Hocoma Company Information
  45. 8.8.2 Hocoma Business Overview
  46. 8.8.3 Hocoma Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
  48. 8.8.5 Hocoma Recent Developments
  49. 8.9 Ekso Bionics
  50. 8.9.1 Ekso Bionics Company Information
  51. 8.9.2 Ekso Bionics Business Overview
  52. 8.9.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
  54. 8.9.5 Ekso Bionics Recent Developments
  55. 8.10 Cyberdyne
  56. 8.10.1 Cyberdyne Company Information
  57. 8.10.2 Cyberdyne Business Overview
  58. 8.10.3 Cyberdyne Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
  60. 8.10.5 Cyberdyne Recent Developments
  61. 8.11 B-TEMIA Inc.
  62. 8.11.1 B-TEMIA Inc. Company Information
  63. 8.11.2 B-TEMIA Inc. Business Overview
  64. 8.11.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
  66. 8.11.5 B-TEMIA Inc. Recent Developments
  67. 8.12 Alter G
  68. 8.12.1 Alter G Company Information
  69. 8.12.2 Alter G Business Overview
  70. 8.12.3 Alter G Exoskeleton Enhancement Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alter G Exoskeleton Enhancement Device Product Portfolio
  72. 8.12.5 Alter G Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exoskeleton Enhancement Device Value Chain Analysis
  2. 9.1.1 Exoskeleton Enhancement Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exoskeleton Enhancement Device Production Mode & Process
  6. 9.2 Exoskeleton Enhancement Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exoskeleton Enhancement Device Distributors
  9. 9.2.3 Exoskeleton Enhancement Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst